| 1 | like | 5,062 |
| 2 | resembling | 211 |
| 3 | protein-coated | 6 |
| 4 | overrode | 4 |
| 5 | d-induced | 3 |
| 6 | incentivizes | 3 |
| 7 | society-unified | 3 |
| 8 | acry | 2 |
| 9 | appling | 2 |
| 10 | counter-regulate | 2 |
| 11 | e.g.. | 2 |
| 12 | ellagitannin-derived | 2 |
| 13 | inaugurating | 2 |
| 14 | motif-induced | 2 |
| 15 | serglycin | 2 |
| 16 | silhouetting | 2 |
| 17 | xianglian | 2 |
| 18 | 'trichomonas | 1 |
| 19 | +30282 | 1 |
| 20 | 2-amino-1,3,4-thiadiazolium | 1 |
| 21 | a=b=c=118.5 | 1 |
| 22 | acupoints+ | 1 |
| 23 | agents.although | 1 |
| 24 | albumin-peg | 1 |
| 25 | ampicillin/kanamycin-gentamicin/ | 1 |
| 26 | application-with | 1 |
| 27 | compared-with | 1 |
| 28 | counselors-without | 1 |
| 29 | excess-vital | 1 |
| 30 | fwor | 1 |
| 31 | infectieuses | 1 |
| 32 | j01d | 1 |
| 33 | katip | 1 |
| 34 | oculaires | 1 |
| 35 | of/in | 1 |
| 36 | out-competes | 1 |
| 37 | oxaloacetate-derived | 1 |
| 38 | polyneuro-and/or | 1 |
| 39 | presence-non-enzymatic | 1 |
| 40 | purasolve | 1 |
| 41 | treatments-including | 1 |
| 42 | trial/ | 1 |
| 1 | 'trichomonas | 1 |
| 2 | +30282 | 1 |
| 3 | 2-amino-1,3,4-thiadiazolium | 1 |
| 4 | a=b=c=118.5 | 1 |
| 5 | acry | 2 |
| 6 | acupoints+ | 1 |
| 7 | agents.although | 1 |
| 8 | albumin-peg | 1 |
| 9 | ampicillin/kanamycin-gentamicin/ | 1 |
| 10 | application-with | 1 |
| 11 | appling | 2 |
| 12 | compared-with | 1 |
| 13 | counselors-without | 1 |
| 14 | counter-regulate | 2 |
| 15 | d-induced | 3 |
| 16 | e.g.. | 2 |
| 17 | ellagitannin-derived | 2 |
| 18 | excess-vital | 1 |
| 19 | fwor | 1 |
| 20 | inaugurating | 2 |
| 21 | incentivizes | 3 |
| 22 | infectieuses | 1 |
| 23 | j01d | 1 |
| 24 | katip | 1 |
| 25 | like | 5,062 |
| 26 | motif-induced | 2 |
| 27 | oculaires | 1 |
| 28 | of/in | 1 |
| 29 | out-competes | 1 |
| 30 | overrode | 4 |
| 31 | oxaloacetate-derived | 1 |
| 32 | polyneuro-and/or | 1 |
| 33 | presence-non-enzymatic | 1 |
| 34 | protein-coated | 6 |
| 35 | purasolve | 1 |
| 36 | resembling | 211 |
| 37 | serglycin | 2 |
| 38 | silhouetting | 2 |
| 39 | society-unified | 3 |
| 40 | treatments-including | 1 |
| 41 | trial/ | 1 |
| 42 | xianglian | 2 |
| 1 | acupoints+ | 1 |
| 2 | e.g.. | 2 |
| 3 | trial/ | 1 |
| 4 | ampicillin/kanamycin-gentamicin/ | 1 |
| 5 | +30282 | 1 |
| 6 | a=b=c=118.5 | 1 |
| 7 | presence-non-enzymatic | 1 |
| 8 | j01d | 1 |
| 9 | d-induced | 3 |
| 10 | motif-induced | 2 |
| 11 | society-unified | 3 |
| 12 | protein-coated | 6 |
| 13 | oxaloacetate-derived | 1 |
| 14 | ellagitannin-derived | 2 |
| 15 | overrode | 4 |
| 16 | like | 5,062 |
| 17 | counter-regulate | 2 |
| 18 | purasolve | 1 |
| 19 | albumin-peg | 1 |
| 20 | treatments-including | 1 |
| 21 | resembling | 211 |
| 22 | appling | 2 |
| 23 | inaugurating | 2 |
| 24 | silhouetting | 2 |
| 25 | agents.although | 1 |
| 26 | compared-with | 1 |
| 27 | application-with | 1 |
| 28 | excess-vital | 1 |
| 29 | 2-amino-1,3,4-thiadiazolium | 1 |
| 30 | xianglian | 2 |
| 31 | of/in | 1 |
| 32 | serglycin | 2 |
| 33 | katip | 1 |
| 34 | polyneuro-and/or | 1 |
| 35 | fwor | 1 |
| 36 | 'trichomonas | 1 |
| 37 | oculaires | 1 |
| 38 | infectieuses | 1 |
| 39 | out-competes | 1 |
| 40 | incentivizes | 3 |
| 41 | counselors-without | 1 |
| 42 | acry | 2 |